SUMMARY
The concentration of C-reactive protein (CRP) in sera from 70 patients with systemic lupus erythematosus (SLE) showed no correlation with commonly accepted laboratory indices of disease activity. Most patients had detectable serum CRP, but in some patients CRP was not found despite repeated testing. This absence of a CRP response did not appear to be related to medication. In some patients high levels of CRP were seen in the absence of infection. Measurement of serum CRP in SLE is unlikely to be useful in the laboratory diagnosis of disease activity. Si conversion: CRP Ag/ml x 1 =mg/I. Although we did not attempt to examine fully the acute-phase proteins in this study, it is of interest that all patients had either normal or elevated a1 AT levels. A report on serum amyloid-A protein (SAA), another acute-phase protein, in a number of inflammatory diseases, including SLE, has recently been published.20 SAA levels were found to be lower in SLE than rheumatoid arthritis and juvenile chronic arthritis and tended to parallel CRP concentrations in these diseases. There are many other acute-phase proteins, and a more comprehensive study of their behaviour in SLE would be particularly interesting.
There was a significant correlation between elevated DNA Abs, low C3, and low C4, confirming the impression that these indices tend to parallel each other. The lack of correlation with CICs is undoubtedly due to the fluid phase assay used. It is well recognised that the solid phase Clq binding assay is more specific for the CICs found in SLE.21
In conclusion, CRP levels do not correlate with some of the commonly accepted indices of disease activity in SLE and are not likely to be helpful in the laboratory assessment of disease activity. 
